Danese S - Search Results

1

First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

Peyrin-Biroulet L, Fiorino G, Buisson A, Danese S. Peyrin-Biroulet L, et al. Among authors: danese s. Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):345-51. doi: 10.1038/nrgastro.2013.31. Epub 2013 Mar 5. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23458890 Review.

2

Early combined immunosuppression in Crohn's disease.

Danese S, Peyrin-Biroulet L. Danese S, et al. Lancet. 2008 Jun 14;371(9629):1996; author reply 1996-7. doi: 10.1016/S0140-6736(08)60862-4. Lancet. 2008. PMID: 18555908 No abstract available.

3

Step-up and top-down approaches to the treatment of Crohn's disease: early may already be too late.

Peyrin-Biroulet L, Bigard MA, Malesci A, Danese S. Peyrin-Biroulet L, et al. Among authors: danese s. Gastroenterology. 2008 Oct;135(4):1420-2. doi: 10.1053/j.gastro.2008.08.017. Epub 2008 Sep 4. Gastroenterology. 2008. PMID: 18773901 No abstract available.

4

Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease.

Fiorino G, Allez M, Malesci A, Danese S. Fiorino G, et al. Among authors: danese s. Aliment Pharmacol Ther. 2009 May 1;29(9):921-7. doi: 10.1111/j.1365-2036.2009.03955.x. Epub 2009 Feb 10. Aliment Pharmacol Ther. 2009. PMID: 19210297 Free article. Review.

5

Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases.

Szabò H, Fiorino G, Spinelli A, Rovida S, Repici A, Malesci AC, Danese S. Szabò H, et al. Among authors: danese s. Aliment Pharmacol Ther. 2010 Jan 15;31(2):189-201. doi: 10.1111/j.1365-2036.2009.04171.x. Epub 2009 Oct 13. Aliment Pharmacol Ther. 2010. PMID: 19832726 Free article. Review.

6

Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review.

Oussalah A, Danese S, Peyrin-Biroulet L. Oussalah A, et al. Among authors: danese s. Curr Drug Targets. 2010 Feb;11(2):156-75. doi: 10.2174/138945010790309939. Curr Drug Targets. 2010. PMID: 20210765 Review.

7

Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner?

Fiorino G, Rovida S, Correale C, Malesci A, Danese S. Fiorino G, et al. Among authors: danese s. Curr Drug Targets. 2010 Feb;11(2):249-60. doi: 10.2174/138945010790309975. Curr Drug Targets. 2010. PMID: 20210771 Review.

8

New drug delivery systems in inflammatory bowel disease: MMX and tailored delivery to the gut.

Fiorino G, Fries W, De La Rue SA, Malesci AC, Repici A, Danese S. Fiorino G, et al. Among authors: danese s. Curr Med Chem. 2010;17(17):1851-7. doi: 10.2174/092986710791111170. Curr Med Chem. 2010. PMID: 20353384 Review.

9

Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study.

Danese S, Fiorino G, Angelucci E, Vetrano S, Pagano N, Rando G, Spinelli A, Malesci A, Repici A. Danese S, et al. World J Gastroenterol. 2010 May 21;16(19):2396-400. doi: 10.3748/wjg.v16.i19.2396. World J Gastroenterol. 2010. PMID: 20480525 Free PMC article.

10

Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease.

Fiorino G, Correale C, Fries W, Repici A, Malesci A, Danese S. Fiorino G, et al. Among authors: danese s. Expert Rev Clin Immunol. 2010 Jul;6(4):567-72. doi: 10.1586/eci.10.40. Expert Rev Clin Immunol. 2010. PMID: 20594130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,186 results

Search Page

Filters